Role of monocytes and eosinophils in human respiratory syncytial virus infection in vitro.
RSV infection in airway epithelial cells (EC) results in production of the chemokines RANTES and MIP1alpha and the leukocyte differentiation factor GM-CSF. The chemokines attract monocytes and eosinophils to the site of infection, where GM-CSF may influence their function and differentiation. In turn, these inflammatory cells may limit the progression of RSV infection, as well as initiate immune responses. In the present study, the effect of monocytes and eosinophils on viral replication and infection-dependent release of EC-derived cytokines was investigated. The modulation of immune cell costimulatory molecules, CD80, CD86, CD40, and HLA-DR, and the release of the CD4(+) T cell chemoattractant IL-16 were also investigated. Employing immunofluorescence techniques, monocytes and eosinophils in cocultures with infected EC were found to inhibit the spread of RSV to uninfected cells. Monocytes also had a significant effect on replication of RSV. Monocytes phagocytized the virus, while eosinophils inhibited reinfection mainly by extracellular means. The release of G-CSF and GM-CSF in the infected cultures was not significantly affected by either monocytes or eosinophils, while RANTES release was significantly decreased. The expression of CD40, CD80, CD86, and HLA-DR on monocytes, but not on eosinophils, increased in an RSV-dose-dependent manner. IL-16 release was not induced in RSV-infected EC, but was significantly increased in coculture with monocytes. These results suggest that both monocytes and eosinophils attracted to the site of RSV infection play an important role in confining infection, while RSV-exposed monocytes may be involved in promoting/polarizing immune responses to RSV.
Soukup
Joleen M
JM
U.S. Environmental Protection Agency, National Health and Environmental Effects Research Laboratory, Research Triangle Park, NC 27711, USA.
Becker
Susanne
S
D015703:Antigens, CD / Q000276:immunology / Q000378:metabolism; D001798:Blood Proteins / Q000378:metabolism; D001980:Bronchi / Q000276:immunology / Q000821:virology; D002460:Cell Line; D018946:Chemokine CCL5 / Q000096:biosynthesis / Q000276:immunology; D018920:Coculture Techniques; D047091:Eosinophil Granule Proteins; D004804:Eosinophils / Q000276:immunology*; D004847:Epithelial Cells / Q000276:immunology / Q000378:metabolism / Q000821:virology; D005786:Gene Expression Regulation; D016179:Granulocyte Colony-Stimulating Factor / Q000096:biosynthesis / Q000276:immunology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000096:biosynthesis / Q000276:immunology; D006684:HLA-DR Antigens / Q000276:immunology / Q000378:metabolism; D006801:Humans; D019410:Interleukin-16 / Q000096:biosynthesis / Q000276:immunology; D009000:Monocytes / Q000276:immunology*; D012136:Respiratory Syncytial Viruses / Q000276:immunology*; D012260:Ribonucleases
D015703:Antigens, CD; D001798:Blood Proteins; D018946:Chemokine CCL5; D047091:Eosinophil Granule Proteins; D006684:HLA-DR Antigens; D019410:Interleukin-16; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D012260:Ribonucleases